Two genomic wide association studies (GWAS) have identified the CLU gene as a novel risk factor for late-onset AD [98,99], becoming the third most common genetic risk factor after APOE and bridging integrator 1 (BIN1). The gene discussed is APOE; the disease is Alzheimer disease.